3uuo
From Proteopedia
(Difference between revisions)
												
			
			| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
| ==The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia== | ==The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia== | ||
| - | <StructureSection load='3uuo' size='340' side='right' caption='[[3uuo]], [[Resolution|resolution]] 2.11Å' scene=''> | + | <StructureSection load='3uuo' size='340' side='right'caption='[[3uuo]], [[Resolution|resolution]] 2.11Å' scene=''> | 
| == Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3uuo]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3uuo]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3UUO OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3UUO FirstGlance]. <br> | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0CV:6-METHOXY-3,8-DIMETHYL-4-(PIPERAZIN-1-YL)-1H-PYRAZOLO[3,4-B]QUINOLINE'>0CV</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.11Å</td></tr> | 
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0CV:6-METHOXY-3,8-DIMETHYL-4-(PIPERAZIN-1-YL)-1H-PYRAZOLO[3,4-B]QUINOLINE'>0CV</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3uuo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3uuo OCA], [https://pdbe.org/3uuo PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3uuo RCSB], [https://www.ebi.ac.uk/pdbsum/3uuo PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3uuo ProSAT]</span></td></tr> | 
| </table> | </table> | ||
| == Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PDE10_HUMAN PDE10_HUMAN] Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. Can hydrolyze both cAMP and cGMP, but has higher affinity for cAMP and is more efficient with cAMP as substrate.<ref>PMID:17389385</ref>  | 
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| ==See Also== | ==See Also== | ||
| - | *[[Phosphodiesterase|Phosphodiesterase]] | + | *[[Phosphodiesterase 3D structures|Phosphodiesterase 3D structures]] | 
| == References == | == References == | ||
| <references/> | <references/> | ||
| Line 25: | Line 18: | ||
| </StructureSection> | </StructureSection> | ||
| [[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category: Bercovici | + | [[Category: Large Structures]] | 
| - | [[Category: Bleickardt | + | [[Category: Bercovici A]] | 
| - | [[Category: Greenlee | + | [[Category: Bleickardt C]] | 
| - | [[Category: Guzzi | + | [[Category: Greenlee WJ]] | 
| - | [[Category: Ho | + | [[Category: Guzzi M]] | 
| - | [[Category: Hodgson | + | [[Category: Ho GD]] | 
| - | [[Category: Hruza | + | [[Category: Hodgson R]] | 
| - | [[Category: McElroy | + | [[Category: Hruza A]] | 
| - | [[Category: Mckittrick | + | [[Category: McElroy W]] | 
| - | [[Category: Mullins | + | [[Category: Mckittrick B]] | 
| - | [[Category: Nechuta | + | [[Category: Mullins D]] | 
| - | [[Category: Rindgen | + | [[Category: Nechuta T]] | 
| - | [[Category: Smith | + | [[Category: Rindgen D]] | 
| - | [[Category: Smotryski | + | [[Category: Smith EM]] | 
| - | [[Category: Tan | + | [[Category: Smotryski J]] | 
| - | [[Category: Tulshian | + | [[Category: Tan Z]] | 
| - | [[Category: Xiao | + | [[Category: Tulshian D]] | 
| - | [[Category: Yang | + | [[Category: Xiao L]] | 
| - | [[Category: Zhang | + | [[Category: Yang S]] | 
| - | + | [[Category: Zhang X]] | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia
| 
 | |||||||||||
Categories: Homo sapiens | Large Structures | Bercovici A | Bleickardt C | Greenlee WJ | Guzzi M | Ho GD | Hodgson R | Hruza A | McElroy W | Mckittrick B | Mullins D | Nechuta T | Rindgen D | Smith EM | Smotryski J | Tan Z | Tulshian D | Xiao L | Yang S | Zhang X
